OAS3 and COVID-19: IFNAR2 was significantly upregulated in severe COVID-19 patients (FDR = 0.0075, Fig. 3A), and both OAS1 and OAS3 were upregulated in T cells from severe COVID-19 patients compared to those with mild disease (Fig. 3B).